Covalon Technologies (CVALF) to Release Earnings on Thursday

Covalon Technologies (OTCMKTS:CVALF) will likely be posting its results before the market opens on Thursday, December 11th. Analysts expect the company to announce earnings of ($0.04) per share and revenue of $10.4860 million for the quarter.

Covalon Technologies Stock Performance

CVALF opened at $1.37 on Friday. The business’s fifty day moving average is $1.46 and its two-hundred day moving average is $1.68. The company has a market cap of $37.78 million, a price-to-earnings ratio of 27.37 and a beta of 0.43. Covalon Technologies has a one year low of $1.34 and a one year high of $2.76.

Covalon Technologies Company Profile

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company’s platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity.